MiR206 and 423-3p Are Differently Modulated in Fast and Slow-Progressing Amyotrophic Lateral Sclerosis Patients

Area of Science:

• Neurology
• Molecular Biology
• Biochemistry

Background:

• Amyotrophic lateral sclerosis (ALS) is a rare neuromuscular disease with variable progression rates.
• Current biomarkers for ALS have limitations, necessitating the search for novel indicators.
• MicroRNAs (miRs) are implicated in ALS pathogenesis and may offer prognostic value.

Purpose of the Study:

• To investigate the differential modulation of specific microRNAs in fast versus slow-progressing ALS patients.
• To explore the potential of microRNAs as prognostic biomarkers for ALS disease progression.

Main Methods:

• Recruitment of 22 fast and 23 slow-progressing ALS patients.
• Assessment of clinical parameters including ALSFRS-R, muscle strength, respiratory function, nerve conduction studies, and creatine kinase at baseline and 6-month follow-up.
• Quantification of specific microRNAs (miR206, 133a-3p, 151a-5p, 199a-5p, 423-3p) and calculation of progression index (PI).

Main Results:

• Univariate analysis revealed an independent reduction of miR206 in patients with a slower decline in ALSFRS-R.
• An increase in miR423-3p was associated with weakness progression.
• MiR206 and miR423-3p demonstrated differential expression patterns between fast and slow-progressing ALS cohorts.

Conclusions:

• MicroRNA profiles, specifically miR206 and miR423-3p, are distinct in patients with different ALS progression rates.
• These microRNAs hold potential as prognostic indicators for ALS.
• Further research into microRNAs could identify novel therapeutic targets for ALS.